查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2018842

整形外科软组织修復市场：按产品类型、手术类型、材料、应用和最终用户划分－2026-2032年全球市场预测

Orthopedic Soft Tissue Repair Market by Product Type, Surgery Type, Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，整形外科软组织修復市场价值将达到 82.4 亿美元，到 2026 年将成长至 96 亿美元，到 2032 年将达到 235.3 亿美元，年复合成长率为 16.15%。

主要市场统计数据
基准年 2025 82.4亿美元
预计年份：2026年 96亿美元
预测年份 2032 235.3亿美元
复合年增长率 (%) 16.15%

为高阶主管提供的入门框架，概述了塑造整形外科软组织修復生态系统的临床、产品和商业性因素。

本执行摘要重点概述了现代整形外科软组织修復领域，并着重阐述了重塑治疗路径的临床、技术和商业性因素。过去十年，临床医生和製造商之间的合作不断深化，重点关注材料科学、微创技术和生物活性结构。因此，我们对肌腱和韧带病变修復策略的理解也更加深入。本导言透过概述推动应用趋势和采购重点的关键产品线、手术方法和终端用户环境，阐明了本报告的范围。

对正在迅速改变整形外科软组织修復实务和采购的技术、临床和商业性转折点进行简要分析。

整形外科软组织修復领域正经历着一场变革，这主要得益于生物材料、外科技术和以价值为导向的医疗模式的进步。支架材料化学性质的创新和生物材料增强技术的进步拓展了临床选择，同时，缝合锚钉和微创手术器械机械动态的提升降低了术中操作的复杂性。这些技术进步正在改变临床医生的期望。能够缩短手术时间、提供可重复的固定强度以及与生物组织整合的材料正日益成为其应用的关键要素。

重点评估 2025 年关税调整如何重塑整个整形外科软组织修復领域的筹资策略、供应链韧性和采购实践。

2025年关税的实施和贸易政策的调整为整形外科软组织修復价值链上的相关人员带来了新的挑战。关税正在影响进口零件和成品的成本结构，其连锁反应波及供应商谈判、定价策略以及医院采购流程。为了应对这些挑战，製造商被迫重新评估其采购地点，加快本地供应商的认证进程，并在某些情况下重新设计零件，以使用国产原材料或性能相当的替代材料。

深入洞察高解析度细分，将产品设计、临床适应症、终端用户趋势、外科技术和材料科学与产品引进和商业化途径联繫起来。

细分市场层面的洞察揭示了每种产品、应用、最终用户、手术方法和材料组合的不同驱动因素和应用障碍，为制定有针对性的策略提供了详细的依据。从产品类型来看，贴片、支架、缝合锚钉和缝线各自占据着独特的临床应用领域和商业管道。贴片用于覆盖和增强生物组织，可分为无细胞真皮基质贴片、胶原蛋白贴片和合成贴片。支架促进组织浸润，包括同种异体支架、合成支架和异种移植支架。缝合锚钉提供固定作用，包括全缝线锚钉、生物可吸收锚钉和金属锚钉。另一方面，缝线包括倒刺缝线、编织缝线和单丝缝线，每种缝线都有不同的操作性和强度特性。

一项全面的区域分析揭示了美洲、欧洲、中东和非洲以及亚太地区的趋势如何以独特的方式影响临床引入、监管和商业策略。

区域趋势影响临床实务模式、管理体制、报销方式和供应链考量，为市场参与企业带来各种机会和挑战。在美洲，手术量、完善的医疗设备註册体係以及对临床结果的高度重视，推动了对具有充分对比证据和成本效益论证的医疗设备的需求。门诊治疗的趋势特别显着，促使人们倾向于选择操作简单、方便快速学习的医疗设备。

深入的竞争分析，重点阐述了产品系列、证据计划、伙伴关係和卓越营运如何创造差异化和商业性吸引力。

整形外科软组织修復领域的竞争格局由成熟的医疗设备製造商和敏捷的创新者组成，它们在材料科学、临床证据包和生态系统支援服务方面图。主要企业在产品性能、易用性和可重复的临床结果验证方面展开竞争，而新参与企业则倾向于专注于利基产品创新、经济高效的替代材料或支持手术规划和培训的数位化工具。策略伙伴关係、分销联盟和有针对性的收购是确保获得互补技术和扩大地域覆盖范围的常用方法。

为领导者提供可操作的建议，以整合证据、供应链韧性和客製化商业化，从而在整形外科软组织修復市场中超越竞争对手。

产业领导企业应采取多管齐下的策略，整合临床证据的累积、供应链韧性以及精准的商业化，以在整形外科软组织修復领域建立可持续的竞争优势。首先，他们应优先开发可靠的对比临床数据和真实世界结果，以证明修復的持久性、再次手术率以及患者报告的功能改善。这些数据将构成医保报销讨论和医院采购决策的基础。其次，他们应投资于供应链多元化和本地供应商认证，以降低贸易带来的成本压力，并提高对临床需求波动的应对力。

严谨的混合方法研究框架，结合了临床访谈、监管审查、材料分析和贸易政策评估，以检验实践见解。

本分析的调查方法结合了结构化的初步访谈、二手文献整合、医疗设备监管申报文件审查以及对比临床证据评估，以确保获得可靠且可操作的见解。主要资讯来源包括对骨科医生、供应链经理、医院采购负责人和监管专家的访谈，旨在收集他们对医疗设备性能、推广障碍和采购标准的第一手观点。这些定性数据与同行评审的临床研究、监管核准和公开的手术基准进行交叉比对，以检验观察到的趋势并为临床结论提供背景资讯。

一份简洁、全面的分析报告，重点阐述了材料创新、临床证据需求以及整形外科软组织修復成功所需的营运韧性。

总之，以下核心主题相互融合：材料和固定技术的创新正在改变临床实践；报销体系和医疗服务环境的转变正在重新定义价值预期；贸易政策趋势正在促使供应链做出策略性调整。所有这些因素共同要求製造商采取综合方法，将可证实的临床效益与切实可行的商业性可行性结合。临床数据和真实世界证据仍然是推动医院采纳和实现良好采购结果的关键，而能够适应多种手术技术的高度灵活的产品设计则扩大了临床效用和市场覆盖面。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章整形外科软组织修復市场：依产品类型划分

  • 修补
    • 无细胞真皮基质
    • 胶原蛋白贴片
    • 合成贴片
  • 鹰架
    • 用于同种移植的支架
    • 合成支架
    • 异种移植支架
  • 缝合锚钉
    • 全缝合锚
    • 生物可吸收锚
    • 金属锚
  • 缝合线
    • 倒刺缝合线
    • 编织缝合线
    • 单丝缝合线

第九章：整形外科软组织修復市场：依手术类型划分

  • 关节镜
  • 微创
  • 开放性手术

第十章整形外科软组织修復市场：依材料分类

  • 生物可吸收聚合物
    • PGA
    • PLGA
    • PLLA
  • 生物材料
    • 胶原蛋白
    • 玻尿酸
  • 金属
    • 不銹钢
    • 钛
  • 非吸收性聚合物
    • 聚酯纤维
    • UHMWPE

第十一章整形外科软组织修復市场：按应用领域划分

  • 跟腱修復
  • 前十字韧带修復
  • 半月软骨修復
  • 肩旋板修復

第十二章整形外科软组织修復市场：依最终用户划分

  • 门诊手术中心
  • 医院
  • 专科诊所

第十三章整形外科软组织修復市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章整形外科软组织修復市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章整形外科软组织修復市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 美国：整形外科软组织修復市场

第十七章 中国：整形外科软组织修復市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Aroa Biosurgery Ltd.
  • Artelon
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson & Co.
  • Bioventus Inc.
  • Boston Scientific Corporation
  • ConMed Corporation
  • CryoLife, Inc.
  • DePuy Synthes, Inc.
  • DJO Global, LLC
  • Globus Medical, Inc.
  • Integra LifeSciences Holdings Corporation
  • LifeCell International
  • LifeNet Health, Inc.
  • Medtronic plc
  • MTF Biologics
  • Organogenesis Inc.
  • Orthofix Medical Inc.
  • Parcus Medical, LLC
  • RTI Surgical Holdings, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Tissue Regenix Group plc
  • Wright Medical Group NV
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-ED54C46E8E67

The Orthopedic Soft Tissue Repair Market was valued at USD 8.24 billion in 2025 and is projected to grow to USD 9.60 billion in 2026, with a CAGR of 16.15%, reaching USD 23.53 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.24 billion
Estimated Year [2026] USD 9.60 billion
Forecast Year [2032] USD 23.53 billion
CAGR (%) 16.15%

An introductory framework that orients executives to clinical drivers, product families, and commercial levers shaping the orthopedic soft tissue repair ecosystem

This executive summary provides a focused introduction to the contemporary orthopedic soft tissue repair environment, emphasizing the clinical, technological, and commercial forces reshaping care pathways. Over the past decade, clinicians and manufacturers have steadily aligned around materials science, minimally invasive techniques, and biologically active constructs, leading to a more nuanced understanding of repair strategies across tendon and ligament pathologies. The introduction frames the scope of the report by outlining the principal product families, surgical approaches, and end-user settings that determine adoption dynamics and procurement priorities.

Recognizing the interconnected nature of clinician preference, reimbursement drivers, and device innovation, the introduction situates readers to appreciate why certain materials and anchor designs have gained prominence while other solutions are undergoing iterative refinement. This orientation clarifies the interplay between clinical evidence development and commercial execution, underscoring how differentiated clinical outcomes and ease of use influence hospital purchasing committees and ambulatory surgical center contracts. Consequently, strategic leaders will find this introduction useful as a roadmap to the more detailed analysis that follows, enabling targeted exploration of product-level features, application-specific considerations, and regional regulatory contexts.

In sum, the opening section lays out the essential technical vocabulary and market structure that decision-makers need to interpret subsequent insights on competitive positioning, regulatory shifts, and channel strategies for orthopedic soft tissue repair

A concise analysis of technological, clinical, and commercial inflection points driving rapid evolution in orthopedic soft tissue repair practice and procurement

The landscape for orthopedic soft tissue repair is undergoing transformative shifts driven by converging advances in biomaterials, surgical technique, and value-based care models. Innovation in scaffold chemistry and biologic augmentation has expanded clinical options, while concurrent improvements in suture anchor mechanics and minimally invasive instrumentation have reduced intraoperative complexity. These technological advances are matched by evolving clinician expectations: shorter operating times, reproducible fixation strength, and materials that promote native tissue integration are increasingly non-negotiable attributes for adoption.

Moreover, the changing reimbursement environment and emphasis on ambulatory care pathways are incentivizing solutions that deliver consistent outcomes with lower total episode costs. As a result, manufacturers are prioritizing evidence generation focused on comparative effectiveness and real-world outcomes to support formulary inclusion and hospital credentialing. Meanwhile, supply chain considerations and device consolidation among hospital groups are prompting commercial teams to rethink value propositions and contract strategies.

Taken together, these shifts are catalyzing a move from single-feature competition to comprehensive ecosystem plays that bundle device performance, clinical training, and outcomes support. For manufacturers and health system leaders, the imperative is clear: align product innovation with robust clinical data and pragmatic economic narratives to win in a market that now prizes integrated solutions and demonstrable patient benefit

A focused assessment of how 2025 tariff adjustments are reshaping sourcing strategies, supply chain resilience, and procurement behaviors across the orthopedic soft tissue repair sector

The imposition of tariffs and trade policy adjustments in 2025 has introduced a new layer of complexity for stakeholders engaged in the orthopedic soft tissue repair value chain. Tariffs affect cost structures for imported components and finished devices, reverberating through supplier negotiations, pricing strategies, and hospital procurement processes. In response, manufacturers have been forced to reexamine sourcing footprints, accelerate local supplier qualification, and, in some instances, redesign components to rely on domestically produced feedstock or alternative materials with comparable performance characteristics.

Consequently, supply chain resilience has become a strategic priority. Companies are diversifying supplier bases and increasing inventory buffers to mitigate near-term disruption. At the same time, purchasing organizations are scrutinizing total landed cost, emphasizing transparency around input origin, and exploring longer-term contracting arrangements to stabilize supply and pricing volatility. Clinicians and regulatory teams are also engaged, as material substitutions trigger additional validation and potential clinical comparability exercises.

Importantly, tariffs have highlighted the interdependence of regulatory pathways, customs classifications, and commercial strategy; therefore, cross-functional coordination between compliance, procurement, and commercial teams is now essential. In the medium term, the clearest response to tariff-driven constraints is an intensified focus on design for manufacturability and supplier automation to preserve margins while maintaining clinical performance standards

High-resolution segmentation insights that link product design, clinical indication, end-user dynamics, surgical technique, and material science to adoption and commercialization pathways

Segment-level insights reveal differentiated drivers and adoption barriers across products, applications, end users, surgical approaches, and material sets, offering a granular basis for targeted strategy development. By product type, patches, scaffolds, suture anchors, and sutures each occupy distinct clinical niches and commercial channels: patches are employed for biological coverage and augmentation and can be categorized into acellular dermal matrix, collagen patches, and synthetic patches; scaffolds support tissue in-growth and exist as allograft scaffolds, synthetic scaffolds, and xenograft scaffolds; suture anchors provide fixation options that include all-suture anchors, bioabsorbable anchors, and metal anchors; while sutures encompass barbed sutures, braided sutures, and monofilament sutures with differing handling and strength profiles.

Across applications, procedural requirements vary as clinicians manage Achilles tendon repair, anterior cruciate ligament repair, meniscus repair, and rotator cuff repair, each demanding specific combinations of fixation strength, biological augmentation potential, and instrumentation compatibility. End users such as ambulatory surgical centers, hospitals, and specialty clinics demonstrate different procurement cycles, capital constraints, and clinical workflow expectations that inform product positioning and sales approaches. Regarding surgery type, arthroscopic, minimally invasive, and open procedures have diverging instrumentation needs and training demands, thereby influencing adoption curves for anchors, anchors-with-suture systems, and augmentation materials.

Material selection remains a core determinant of clinical performance and regulatory pathway. Bioabsorbable polymers including PGA, PLGA, and PLLA are often chosen to avoid long-term implant presence, biological materials such as collagen and hyaluronic acid are leveraged to enhance healing, metals like stainless steel and titanium deliver high initial mechanical strength, and nonabsorbable polymers including polyester and ultra-high-molecular-weight polyethylene provide durable fixation. These segmentation distinctions collectively shape value propositions, evidence requirements, and commercialization tactics for developers and commercial teams

Comprehensive regional analysis that delineates how Americas, Europe Middle East & Africa, and Asia-Pacific trends uniquely shape clinical adoption, regulation, and commercial strategy

Regional dynamics influence clinical practice patterns, regulatory regimes, reimbursement approaches, and supply chain considerations, creating varied opportunities and challenges for market participants. In the Americas, procedural volumes, established device registries, and a strong emphasis on clinical outcomes drive demand for devices supported by robust comparative evidence and cost-effectiveness narratives. Transitioning care to outpatient settings is particularly pronounced, and this shift influences device design preferences toward streamlined instrumentation and rapid learning curves.

In Europe, Middle East & Africa, heterogeneous regulatory environments and varied reimbursement mechanisms necessitate tailored market entry strategies; pricing pressures and centralized procurement in some jurisdictions favor solutions that demonstrate clear budgetary advantages or clinical differentiation. Meanwhile, emerging markets in the region present opportunities for cost-effective product adaptations and training partnerships. In the Asia-Pacific area, rapid adoption of minimally invasive techniques and investments in local manufacturing capacity are notable, and regional clinical research contributions are growing. Supply chain localization and partnerships with regional distributors are common strategic responses to address regulatory timelines and logistics. Across all regions, cross-border trade policies, reimbursement evolution, and clinician training programs will continue to shape where and how companies prioritize resource allocation and commercial efforts

Insightful competitive analysis highlighting how product portfolios, evidence programs, partnerships, and operational excellence drive differentiation and commercial traction

Competitive dynamics in orthopedic soft tissue repair reflect a mix of established device manufacturers and nimble innovators, with differentiation driven by material science, clinical evidence packages, and ecosystem support services. Leading players compete on product performance, ease of use, and the ability to demonstrate reproducible clinical outcomes, while newer entrants often focus on niche product innovations, cost-effective material alternatives, or digital tools that support surgical planning and training. Strategic partnerships, distribution alliances, and targeted acquisitions have been common approaches to gain access to complementary technologies or to broaden geographic reach.

Product portfolios that integrate anchors, suture systems, and biologic patches tend to benefit from cross-selling opportunities and deeper clinical engagement, whereas companies specializing in a single product family must emphasize clinical superiority or cost advantages to carve out sustainable positions. Additionally, investment in clinical studies and real-world evidence collection has become a competitive necessity to support hospital formulary placements and payer negotiations. Operationally, efficient manufacturing, quality systems, and supply chain transparency are differentiators that affect contract negotiations and long-term relationships with health systems. For commercial teams, the imperative is to align sales messaging with evidence-based value propositions and to anticipate clinician training needs that facilitate rapid uptake of new technologies

Actionable recommendations for leaders to integrate evidence, supply chain resilience, and tailored commercialization to outperform in orthopedic soft tissue repair markets

Industry leaders should adopt multi-dimensional strategies that integrate clinical evidence generation, supply chain resilience, and focused commercialization to capture durable advantage in orthopedic soft tissue repair. First, prioritize the development of robust comparative clinical data and real-world outcomes that speak to repair durability, reoperation rates, and patient-reported functional gains; these data underpin reimbursement discussions and hospital procurement decisions. Second, invest in supply chain diversification and local supplier qualification to reduce exposure to trade-induced cost pressures and to enhance responsiveness to clinical demand fluctuations.

In parallel, tailor go-to-market initiatives by aligning product configurations and training programs with the needs of ambulatory surgical centers, hospitals, and specialty clinics, recognizing that each end-user segment values different combinations of cost, ease of use, and support. Emphasize modular product platforms that allow rapid adaptation to arthroscopic, minimally invasive, and open techniques, thereby expanding the addressable clinical use cases. From a materials perspective, balance the adoption of bioabsorbable and biological technologies with options that maintain mechanical reliability, and be prepared to substantiate material selections through comparative laboratory and clinical data.

Finally, pursue targeted partnerships for regional distribution and consider value-based contracting pilots with health systems to demonstrate total episode improvements. These integrated actions will position leaders to respond to regulatory shifts, tariff-related cost pressures, and evolving clinician expectations while accelerating adoption and commercial success

A rigorous mixed-methods research framework combining primary clinical interviews, regulatory review, materials analysis, and trade policy assessment to validate actionable insights

The research methodology underpinning this analysis combines structured primary interviews, secondary literature synthesis, device regulatory filings review, and comparative clinical evidence appraisal to ensure robust and actionable insights. Primary inputs include interviews with orthopedic surgeons, supply chain leaders, hospital procurement professionals, and regulatory experts to capture frontline perspectives on device performance, adoption barriers, and purchasing criteria. These qualitative data were triangulated with peer-reviewed clinical studies, regulatory approvals, and publicly available procedural benchmarks to validate observed trends and to contextualize clinical claims.

Secondary research encompassed material science literature, surgical technique guides, and policy documents that illuminate the performance characteristics of bioabsorbable polymers, biological materials, metals, and nonabsorbable polymers, as well as procedural considerations for Achilles tendon, ACL, meniscus, and rotator cuff repairs. Additionally, supply chain and trade policy analyses were performed to assess the operational implications of recent tariff actions and to identify strategic mitigation pathways. Throughout the research process, emphasis was placed on cross-functional validation to ensure that commercial recommendations are grounded in clinical reality and regulatory feasibility.

Where appropriate, sensitivity checks were applied to qualitative assertions, and discrepancies were resolved through follow-up interviews or targeted literature reviews. This mixed-methods approach ensures that the findings are practical for decision-makers seeking to align product development, clinical evidence strategies, and go-to-market plans

A concise synthesis highlighting the convergence of materials innovation, clinical evidence imperatives, and operational resilience required to succeed in orthopedic soft tissue repair

The conclusion synthesizes core themes: innovation in materials and fixation technologies is reshaping clinical practice, reimbursement and care setting transitions are redefining value expectations, and trade policy dynamics are prompting strategic supply chain responses. Together, these forces require manufacturers to pursue an integrated approach that couples demonstrable clinical benefit with pragmatic commercial execution. Clinical data and real-world evidence remain central to unlocking hospital adoption and favorable procurement outcomes, while adaptable product designs that support multiple surgical techniques expand clinical utility and market reach.

Moreover, the tariff-driven adjustments to sourcing economics underscore the need for proactive supplier strategies and design-for-manufacturing initiatives that preserve performance while controlling costs. Commercially, segment-specific go-to-market motions-tailored for ambulatory surgical centers versus hospitals or specialty clinics-will be critical to accelerate uptake and to secure preferred vendor status. Finally, companies that invest in clinician education, streamlined instrumentation, and evidence that highlights patient-centered outcomes will be positioned to capture sustained adoption as payment models emphasize value and outcomes.

In closing, the sector presents meaningful opportunities for organizations that can harmonize technical excellence, clinical validation, and resilient operations, thereby delivering solutions that meet the dual imperatives of improved patient outcomes and institutional efficiency

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Orthopedic Soft Tissue Repair Market, by Product Type

  • 8.1. Patches
    • 8.1.1. Acellular Dermal Matrix
    • 8.1.2. Collagen Patches
    • 8.1.3. Synthetic Patches
  • 8.2. Scaffolds
    • 8.2.1. Allograft Scaffolds
    • 8.2.2. Synthetic Scaffolds
    • 8.2.3. Xenograft Scaffolds
  • 8.3. Suture Anchors
    • 8.3.1. All-Suture Anchors
    • 8.3.2. Bioabsorbable Anchors
    • 8.3.3. Metal Anchors
  • 8.4. Sutures
    • 8.4.1. Barbed Sutures
    • 8.4.2. Braided Sutures
    • 8.4.3. Monofilament Sutures

9. Orthopedic Soft Tissue Repair Market, by Surgery Type

  • 9.1. Arthroscopic
  • 9.2. Minimally Invasive
  • 9.3. Open

10. Orthopedic Soft Tissue Repair Market, by Material

  • 10.1. Bioabsorbable Polymers
    • 10.1.1. PGA
    • 10.1.2. PLGA
    • 10.1.3. PLLA
  • 10.2. Biological Material
    • 10.2.1. Collagen
    • 10.2.2. Hyaluronic Acid
  • 10.3. Metal
    • 10.3.1. Stainless Steel
    • 10.3.2. Titanium
  • 10.4. Nonabsorbable Polymers
    • 10.4.1. Polyester
    • 10.4.2. UHMWPE

11. Orthopedic Soft Tissue Repair Market, by Application

  • 11.1. Achilles Tendon Repair
  • 11.2. Anterior Cruciate Ligament Repair
  • 11.3. Meniscus Repair
  • 11.4. Rotator Cuff Repair

12. Orthopedic Soft Tissue Repair Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
  • 12.3. Specialty Clinics

13. Orthopedic Soft Tissue Repair Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Orthopedic Soft Tissue Repair Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Orthopedic Soft Tissue Repair Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Orthopedic Soft Tissue Repair Market

17. China Orthopedic Soft Tissue Repair Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Aroa Biosurgery Ltd.
  • 18.6. Artelon
  • 18.7. Arthrex, Inc.
  • 18.8. B. Braun Melsungen AG
  • 18.9. Becton, Dickinson & Co.
  • 18.10. Bioventus Inc.
  • 18.11. Boston Scientific Corporation
  • 18.12. ConMed Corporation
  • 18.13. CryoLife, Inc.
  • 18.14. DePuy Synthes, Inc.
  • 18.15. DJO Global, LLC
  • 18.16. Globus Medical, Inc.
  • 18.17. Integra LifeSciences Holdings Corporation
  • 18.18. LifeCell International
  • 18.19. LifeNet Health, Inc.
  • 18.20. Medtronic plc
  • 18.21. MTF Biologics
  • 18.22. Organogenesis Inc.
  • 18.23. Orthofix Medical Inc.
  • 18.24. Parcus Medical, LLC
  • 18.25. RTI Surgical Holdings, Inc.
  • 18.26. Smith & Nephew plc
  • 18.27. Stryker Corporation
  • 18.28. Tissue Regenix Group plc
  • 18.29. Wright Medical Group N.V.
  • 18.30. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SURGERY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ACELLULAR DERMAL MATRIX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ACELLULAR DERMAL MATRIX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ACELLULAR DERMAL MATRIX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COLLAGEN PATCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COLLAGEN PATCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COLLAGEN PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SYNTHETIC PATCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SYNTHETIC PATCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SYNTHETIC PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ALLOGRAFT SCAFFOLDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ALLOGRAFT SCAFFOLDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ALLOGRAFT SCAFFOLDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SYNTHETIC SCAFFOLDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SYNTHETIC SCAFFOLDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SYNTHETIC SCAFFOLDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY XENOGRAFT SCAFFOLDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY XENOGRAFT SCAFFOLDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY XENOGRAFT SCAFFOLDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ALL-SUTURE ANCHORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ALL-SUTURE ANCHORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ALL-SUTURE ANCHORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE ANCHORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE ANCHORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE ANCHORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL ANCHORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL ANCHORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL ANCHORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BARBED SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BARBED SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BARBED SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BRAIDED SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BRAIDED SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BRAIDED SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MONOFILAMENT SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MONOFILAMENT SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MONOFILAMENT SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ARTHROSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ARTHROSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ARTHROSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY OPEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY OPEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PGA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PGA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PGA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PLGA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PLGA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PLGA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PLLA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PLLA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PLLA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COLLAGEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COLLAGEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY HYALURONIC ACID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY HYALURONIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY UHMWPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY UHMWPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY UHMWPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ACHILLES TENDON REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ACHILLES TENDON REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ACHILLES TENDON REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ANTERIOR CRUCIATE LIGAMENT REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MENISCUS REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MENISCUS REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MENISCUS REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ROTATOR CUFF REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ROTATOR CUFF REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY ROTATOR CUFF REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. GCC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 261. GCC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. GCC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 263. GCC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, 2018-2032 (USD MILLION)
  • TABLE 264. GCC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, 2018-2032 (USD MILLION)
  • TABLE 265. GCC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 266. GCC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. GCC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 268. GCC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 269. GCC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 270. GCC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 271. GCC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 272. GCC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. GCC ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SCAFFOLDS, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURE ANCHORS, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY BIOLOGICAL MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY NONABSORBABLE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS ORTHOPEDIC SOFT TISSUE REPAIR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS ORTHOPEDIC SOFT TISSUE RE